查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1874589

全球細胞分離技術市場

Cell Separation Technologies
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球細胞分離技術市場預計2030年將達到598億美元

全球細胞分離技術市場規模在2024年估計為257億美元，預計到2030年將達到598億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為15.1%。本報告分析的細分市場之一「實驗室和研究機構」預計將以14.9%的複合年成長率成長，並在分析期結束時達到249億美元。同時，「生物技術和製藥」細分市場預計在分析期間將以16.4%的複合年成長率成長。

美國市場規模估計為71億美元，而中國市場預計將以14.1%的複合年成長率成長。

預計2024年，美國細胞分離技術市場規模將達71億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到90億美元，2024年至2030年的複合年成長率（CAGR）為14.1%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期內，這兩個國家的複合年成長率將分別達到13.2%和12.6%。在歐洲，德國的複合年成長率預計將達到約11.0%。

全球細胞分離技術市場—主要市場趨勢與促進因素概述

細胞分離技術如何推動生物醫學研究？

細胞分離技術正逐漸成為生物醫學研究的基石。它們使科學家能夠從異質混合物中分離出特定類型的細胞，從而為研究疾病機制、開發治療方法和進行基礎生物學研究提供關鍵支持。這些技術在免疫學、癌症研究和幹細胞生物學等應用領域至關重要，因為在這些領域中，分離特定細胞群對於理解細胞行為和功能至關重要。例如，精確分離免疫細胞使研究人員能夠研究身體對感染疾病和治療方法的免疫反應，從而開發新型免疫療法。在癌症研究中，將癌細胞與正常細胞分離可以對癌症進展和治療反應進行詳細分析。包括磁激活細胞分選（MACS）、螢光激活細胞分選（FACS）和微流體系統在內的各種技術被廣泛用於實現這些目標，每種技術都根據細胞類型和所需的精度提供獨特的優勢。這些技術在研究和臨床環境中的廣泛應用，正使其在學術界和工業界的實驗室中日益重要。

為什麼細胞分離技術在治療藥物研發中如此重要？

細胞分離技術在治療方法研發中發揮著至關重要的作用，尤其是在細胞治療方法和個人化醫療領域。在再生醫學和免疫療法等領域，分離特定細胞類型對於生成可用於治療的高純度細胞群至關重要。例如，在CAR-T細胞療法中，免疫細胞被分離、基因改造和擴增，然後重新注射到患者體內標靶化並摧毀癌細胞。分離細胞的純度和活性是治療成功的關鍵。同樣，幹細胞療法利用相關技術從骨髓或組織分離幹細胞，用於再生受損組織和治療退化性疾病。除了用於治療方法研發外，這些技術也應用於臨床診斷。從血液或組織樣本中分離特定細胞能夠更準確地檢測和後續觀察疾病。實現高通量和高精度細胞分離的能力為個人化治療方法的開發和精準醫療的發展開闢了新的可能性，在精準醫療中，治療方法將根據每位患者獨特的細胞特徵量身定做。

技術創新如何改善細胞分離技術？

技術進步顯著提高了細胞分離技術的效率、準確性和擴充性，使其在研發和臨床應用中更容易取得且更可靠。其中一項關鍵創新是開發了自動化、高通量細胞分選系統，該系統能夠以最少的人工干預快速處理大量樣本。這些系統在藥物研發和臨床應用中尤其重要，因為速度和精確度至關重要。微流體技術徹底革新了細胞分離，使細胞能夠在微米尺度上操控，實現更精確、更溫和的分選技術。這減少了細胞損傷，提高了分離細胞的存活率。此外，諸如聲學和介電泳分離等無標定技術的進步，為傳統的標記方法提供了替代方案，並能保持細胞完整性，使其適用於精細應用。此外，將人工智慧 (AI) 和機器學習整合到細胞分選工作流程中，提高了我們分析和最佳化分選參數的能力，進一步提升了細胞分離的效率和準確性。這些創新正在推動下一代細胞分離技術的發展，並擴展其在單細胞分析、癌症研究和再生醫學等領域的應用。

細胞分離技術市場的主要成長要素是什麼？

細胞分離技術市場的成長受多種因素驅動，包括細胞研究的進步、個人化醫療的興起以及治療研發中對高純度細胞群日益成長的需求。其中一個關鍵促進因素是，在CAR-T細胞療法和幹細胞療法等細胞療法的研發過程中，對高效細胞分離的需求不斷成長。這些療法需要精確分離特定細胞類型以確保療效和安全性，這推動了對先進分離技術的需求。自動化和高通量分選系統等技術創新使研究人員能夠快速且準確地處理大量樣本，進一步促進了市場成長。此外，基因組學和蛋白​​質組學領域單細胞分析的擴展，為需要高純度細胞群進行深入分子研究的研究人員創造了新的細胞分離技術機會。免疫療法和再生醫學的興起也推動了市場需求，因為這些療法在治療研發中高度依賴分離細胞。此外，政府和私人部門對生命科學研究的投入不斷增加，加上癌症和自體免疫疾病等慢性病的日益普遍，都加速了先進細胞分離技術的需求。這些因素，以及細胞分離技術在臨床診斷和藥物研發領域應用的持續拓展，預計將在未來幾年內推動細胞分離技術市場保持強勁成長。

部分：

依最終用戶分類（研究機構、生技/製藥業、其他最終用戶）

受訪公司範例

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Global Industry Analysts 沒有依賴查詢通用 LLM（大型語言模型）或產業專用的SLM（小型語言模型），而是建立了一個由世界各地領域專家精心整理的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對區域市場的影響，正如全球產業分析師預測的那樣，關稅將改變企業的競爭地位，而企業的競爭地位將取決於其總部所在地、製造地以及進出口（成品和OEM產品）。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP10949

Global Cell Separation Technologies Market to Reach US$59.8 Billion by 2030

The global market for Cell Separation Technologies estimated at US$25.7 Billion in the year 2024, is expected to reach US$59.8 Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Research Laboratories & Institutes End-Use, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$24.9 Billion by the end of the analysis period. Growth in the Biotechnology & Pharmaceutical Industries End-Use segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 14.1% CAGR

The Cell Separation Technologies market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.0 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Cell Separation Technologies Market - Key Trends and Drivers Summarized

How Are Cell Separation Technologies Advancing Biomedical Research?

Cell separation technologies have become fundamental to biomedical research, providing scientists with the ability to isolate specific cell types from heterogeneous mixtures, which is critical for studying disease mechanisms, developing therapies, and conducting basic biological research. These technologies are essential for applications such as immunology, cancer research, and stem cell biology, where isolating specific cell populations is crucial to understanding cellular behavior and function. By enabling the precise separation of immune cells, for instance, researchers can investigate immune responses to infections or therapies, leading to the development of new immunotherapies. In cancer research, separating tumor cells from healthy cells allows for detailed analysis of how cancer progresses and responds to treatments. Various techniques, such as magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic-based systems, are commonly used to achieve these goals, each offering unique advantages depending on the cell type and the level of precision required. The widespread use of these technologies across research and clinical settings has expanded their relevance in both academic and industrial laboratories.

Why Are Cell Separation Technologies Critical for Therapeutic Development?

Cell separation technologies play a pivotal role in therapeutic development, particularly in the creation of cell-based therapies and personalized medicine. In fields such as regenerative medicine and immunotherapy, isolating specific cell types is essential for generating high-purity cell populations that can be used for therapeutic purposes. For example, in CAR-T cell therapy, immune cells are isolated, genetically engineered, expanded, and reintroduced to a patient to target and destroy cancer cells. The purity and viability of the isolated cells are critical for the success of these therapies. Similarly, in stem cell therapies, cell separation technologies are used to isolate stem cells from bone marrow or other tissues, allowing for their use in regenerating damaged tissues or treating degenerative diseases. In addition to therapeutic development, these technologies are used in clinical diagnostics, where separating specific cells from blood or tissue samples enables more accurate disease detection and monitoring. The ability to achieve high-throughput and high-precision cell isolation has opened new possibilities in developing targeted treatments and advancing precision medicine, where therapies are tailored to individual patients based on their unique cellular profiles.

How Are Technological Innovations Enhancing Cell Separation Techniques?

Technological advancements have significantly enhanced the efficiency, accuracy, and scalability of cell separation technologies, making them more accessible and reliable for both research and clinical applications. One of the key innovations is the development of automated, high-throughput cell sorting systems, which enable the rapid processing of large sample volumes with minimal human intervention. These systems are particularly valuable in drug discovery and clinical settings, where speed and precision are critical. Microfluidic technologies, which allow for the manipulation of cells at the microscale, have revolutionized cell separation by enabling more precise and gentle sorting methods, reducing cell damage and improving the viability of isolated cells. Additionally, advancements in label-free techniques, such as acoustic and dielectrophoresis-based separation, provide alternatives to traditional labeling methods, preserving cell integrity and making these technologies suitable for sensitive applications. Moreover, the integration of artificial intelligence (AI) and machine learning into cell sorting workflows has improved the ability to analyze and optimize sorting parameters, further increasing the efficiency and accuracy of cell separation. These innovations are driving the next generation of cell separation technologies, expanding their applications in areas like single-cell analysis, cancer research, and regenerative medicine.

What Are the Key Growth Drivers in the Cell Separation Technologies Market?

The growth in the cell separation technologies market is driven by several factors, including advancements in cell-based research, the rise of personalized medicine, and the increasing demand for high-purity cell populations in therapeutic development. One of the primary drivers is the growing need for efficient cell separation in the development of cell-based therapies, such as CAR-T cell therapy and stem cell treatments. These therapies require the precise isolation of specific cell types to ensure their effectiveness and safety, fueling demand for advanced separation technologies. Technological innovations, such as automated and high-throughput sorting systems, are making it easier for researchers to process large numbers of samples quickly and accurately, further contributing to market growth. Additionally, the expansion of single-cell analysis in genomics and proteomics is creating new opportunities for cell separation technologies, as researchers require highly purified cell populations for detailed molecular studies. The rise of immunotherapy and regenerative medicine, both of which rely heavily on isolated cells for treatment development, is also driving demand. Furthermore, increasing government and private investment in life sciences research, coupled with the growing prevalence of chronic diseases like cancer and autoimmune disorders, is accelerating the need for advanced cell separation techniques. These factors, along with the expanding use of cell separation in clinical diagnostics and drug discovery, are expected to sustain the robust growth of the cell separation technologies market in the years to come.

SCOPE OF STUDY:

The report analyzes the Cell Separation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Separation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Expands Use of Cell Separation in Diagnostics and Research
    • Rising Demand for Immunotherapy Expands Market for Cell Separation Technologies
    • Advancements in Microfluidics Propel Growth in Precision Cell Separation
    • Increasing Focus on Single-Cell Analysis Drives Adoption of Advanced Separation Technologies
    • Growing Application of Cell Separation in Cancer Research Strengthens Market Growth
    • Expansion of Stem Cell Therapy Boosts Demand for Efficient Cell Separation Solutions
    • Increased Need for High-Purity Cells in Biopharmaceutical Production Fuels Market Expansion
    • Rising Use of Cell Separation Technologies in Personalized Medicine Propels Market Growth
    • Adoption of Magnetic and Fluorescence-Activated Cell Sorting (MACS and FACS) Strengthens Cell Separation Market
    • Advances in Acoustic and Dielectrophoresis-Based Separation Drive Innovation in the Market
    • Increased Focus on Regenerative Medicine Fuels Demand for Sophisticated Cell Separation Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Separation Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biotechnology & Pharmaceutical Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION